Zhejiang Garden Biopharmaceutical Hits Day High with Strong 6.13% Surge

Zhejiang Garden Biopharmaceutical Co., Ltd. has experienced a notable increase of 6.13% on June 16, 2026, reaching an intraday high of CNY 16.53. This performance stands in contrast to the China Shanghai Composite, which saw a slight decline of 0.11% on the same day. Over the past week, the stock has surged by 40.83%, significantly outperforming the broader market index, which gained only 2.04%. In terms of longer-term performance, Zhejiang Garden Biopharmaceutical has shown a 16.08% increase over the past month, while its one-year performance reflects a decline of 5.38%. The company's market capitalization is approximately CNY 5,774 million, placing it in the mid-cap category within the pharmaceuticals and biotechnology sector. Key financial metrics indicate a price-to-earnings ratio of 23.00 and a return on equity of 7.22%. Despite the recent uptick in stock price, the company has faced challenges, including a decline in profits by 18.3% over the past year. The stock's dividend yield stands at 1.08%, providing some return to shareholders amidst fluctuating performance indicators.